Literature DB >> 27830566

ACE Inhibitors and Sarcopenia: Covering All the BASEs?

Jochen Springer1, Stephan von Haehling2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27830566     DOI： 10.1007/s40266-016-0417-7

Source DB:  PubMed          Journal:  Drugs Aging        ISSN： 1170-229X            Impact factor:   3.923


× No keyword cloud information.
  23 in total

1.  Angiotensin-converting enzyme inhibition attenuates myonuclear addition in overloaded slow-twitch skeletal muscle.

Authors:  Christopher M Westerkamp; Scott E Gordon
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-06-16       Impact factor: 3.619

2.  Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study.

Authors:  Stefan D Anker; Abdissa Negassa; Andrew J S Coats; Rizwan Afzal; Philip A Poole-Wilson; Jay N Cohn; Salim Yusuf
Journal:  Lancet       Date:  2003-03-29       Impact factor: 79.321

3.  Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II.

Authors:  Koichi Yamamoto; Mitsuru Ohishi; Tomohiro Katsuya; Norihisa Ito; Masashi Ikushima; Masaharu Kaibe; Yuji Tatara; Atsushi Shiota; Sumio Sugano; Satoshi Takeda; Hiromi Rakugi; Toshio Ogihara
Journal:  Hypertension       Date:  2006-02-27       Impact factor: 10.190

4.  Late-life enalapril administration induces nitric oxide-dependent and independent metabolic adaptations in the rat skeletal muscle.

Authors:  Emanuele Marzetti; Riccardo Calvani; Jameson DuPree; Hazel A Lees; Silvia Giovannini; Dong-oh Seo; Thomas W Buford; Kindal Sweet; Drake Morgan; Kevin Y E Strehler; Debra Diz; Stephen E Borst; Natasha Moningka; Karina Krotova; Christy S Carter
Journal:  Age (Dordr)       Date:  2012-05-26

5.  Anti-inflammatory effects of the activation of the angiotensin-(1-7) receptor, MAS, in experimental models of arthritis.

Authors:  Kátia Daniela da Silveira; Fernanda Matos Coelho; Angélica Thomáz Vieira; Daniela Sachs; Lívia Corrêa Barroso; Vivian Vasconcelos Costa; Thales Lages Bicalho Bretas; Michael Bader; Lirlândia Pires de Sousa; Tarcília Aparecida da Silva; Robson Augusto Souza dos Santos; Ana Cristina Simões e Silva; Mauro Martins Teixeira
Journal:  J Immunol       Date:  2010-10-08       Impact factor: 5.422

6.  Characterization of angiotensin-converting enzymes 1 and 2 in the soleus and plantaris muscles of rats.

Authors:  T Fernandes; N Y Hashimoto; E M Oliveira
Journal:  Braz J Med Biol Res       Date:  2010-08-27       Impact factor: 2.590

7.  Angiotensin-Converting Enzyme Inhibitors and Parameters of Sarcopenia: Relation to Muscle Mass, Strength and Function: Data from the Berlin Aging Study-II (BASE-II).

Authors:  Dominik Spira; Jeremy Walston; Nikolaus Buchmann; Jivko Nikolov; Ilja Demuth; Elisabeth Steinhagen-Thiessen; Rahel Eckardt; Kristina Norman
Journal:  Drugs Aging       Date:  2016-11       Impact factor: 3.923

8.  Converting enzyme determines plasma clearance of angiotensin-(1-7).

Authors:  K Yamada; S N Iyer; M C Chappell; D Ganten; C M Ferrario
Journal:  Hypertension       Date:  1998-09       Impact factor: 10.190

9.  Expression of the Mas receptor is upregulated in skeletal muscle wasting.

Authors:  María Gabriela Morales; Johanna Abrigo; Carla Meneses; Franco Cisternas; Felipe Simon; Claudio Cabello-Verrugio
Journal:  Histochem Cell Biol       Date:  2014-09-11       Impact factor: 4.304

Review 10.  Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis.

Authors:  Masaru Iwai; Masatsugu Horiuchi
Journal:  Hypertens Res       Date:  2009-05-22       Impact factor: 3.872
View more
  2 in total

Review 1.  New insights into the pathogenesis and treatment of sarcopenia in chronic heart failure.

Authors:  Jiayu Yin; Xiang Lu; Zhiyuan Qian; Weiting Xu; Xiang Zhou
Journal:  Theranostics       Date:  2019-05-31       Impact factor: 11.556

2.  Effects of Functional Training on Sarcopenia in Elderly Women in the Presence or Absence of ACE Inhibitors.

Authors:  Marianna Mile; László Balogh; Gábor Papp; József Márton Pucsok; Krisztina Szabó; Lilla Barna; Zoltán Csiki; István Lekli
Journal:  Int J Environ Res Public Health       Date:  2021-06-19       Impact factor: 3.390
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.